U
uMotif
Biotech & Life Sciences · London, United Kingdom · Founded 2012
Patient-centric eClinical platform for decentralized research data MoreLess
uMotif is a London-based digital health company that offers a patient-centric data capture platform for clinical research. Founded in 2012 by Bruce Hellman and Ben James, the company's mission is to place patients at the heart of clinical studies. The idea was sparked after the co-founders met with two Parkinson's Disease patients who wanted digital tools to better track and understand their condition and healthcare journey. Co-founder Bruce Hellman has a background in clinical trials and an MBA from Imperial College, which provided a strong foundation in business and the importance of user-centric design.
The company provides a software-as-a-service (SaaS) application that enables patients to track their health and self-reported outcomes through a mobile app. This cloud-native platform is designed for pharmaceutical companies, biotechs, contract research organizations (CROs), and academic institutions. It captures regulatory-compliant data such as eConsent, electronic Clinical Outcome Assessments (eCOA), and Patient-Reported Outcomes (ePRO), as well as data from wearable devices. The business model serves clients like AstraZeneca, Abbvie, and Syneos, helping them achieve high rates of data capture (in excess of 90%), improve patient retention, and accelerate research timelines. By focusing on a user-friendly experience, the platform aims to reduce the burden on study participants, leading to higher compliance and data quality.
uMotif's platform supports various study designs, from traditional site-based trials to fully decentralized and post-marketing research. Its solutions include Trial Awareness and Patient Ride with Uber Health to bolster the patient-site relationship. The company has raised a total of $35.4 million over six funding rounds, with its latest Series B round in May 2022 securing $25.5 million, led by Athyrium Capital Management. This funding supports international expansion, particularly in North America, and further platform development.
Keywords: patient-centric data, eClinical platform, clinical research, real-world studies, eCOA, ePRO, decentralized trials, patient engagement, patient-reported outcomes, data capture, health self-management, eConsent, clinical trials software, MedTech, life sciences technology, digital health, symptom tracking, wearable device data, site productivity tools, remote data collection
Company overview
uMotif company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2012
- Headquarters
- London, United Kingdom
- Employees
- 99
- Open positions
- None listed
- Dealroom signal
- 79.7
Valuation & funding
uMotif funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | May 2022 | $26M | $102M | DNV · AlbionVC · Athyrium Capital Management | ↗ |
| SERIES A✓Equity / VC | Sep 2020 | $7.9M | $32M | AlbionVC | ↗ |
| EARLY VC✓Equity / VC | Jun 2018 | $3.2M | $13M | AlbionVC | ↗ |
| GRANT✓Other financing | Sep 2016 | $119K | — | SBRI Healthcare | — |
| GRANT✓Other financing | Sep 2014 | $132K | — | SBRI Healthcare | — |
| GRANTOther financing | Sep 2013 | SBRI Healthcare | ↗ | ||
| GRANT✓Other financing | Mar 2012 | SBRI Healthcare | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $16M | 0% | 101 |
| 2025 | $16M | 0% | 92 |
| 2024 | $16M | 0% | 95 |
| 2023 | $16M | 0% | 112 |
| 2022 | $16M | +71.9% | — |
| 2021 | $9.3M | +39.7% | — |
| 2020 | $6.6M | — | — |
Growth signals
uMotif website traffic
Latest recorded traffic for uMotif is 3.7K monthly website visits, down 27.5% over the last three months. uMotif's team grew 7.6% over the past year.
Comparisons
uMotif compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
uMotif's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on uMotif's cap table
Sourced from Dealroom's funding and investor records.





Global footprint
Where uMotif has talent and traffic
team presence
In the news
Latest news about uMotif
Recent press, funding announcements, and product moves mentioning uMotif — open to read from the original sources.
Market sentiment
What the market is saying about uMotif
An AI-synthesized read of the highest-engagement posts about uMotif on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See uMotif’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







